LIEN · Chicago Atlantic BDC, Inc.
Market Cap
$232.77M
Shares
22.82M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.34
Open$10.25
Day$10.17–10.35
52W close$9.01–11.22
Avg vol 30d58K
Short int107K · 0.5% float · 2.5d
Short vol78%
Last earningsAug 13, 2026
DataFeb 2022–Aug 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Nov 12, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
AI Brief
Q1 FY26 earnings call · May 14, 2026
Q1 FY26
TL;DR. Chicago Atlantic BDC (LIEN) reported record Q1 2026 results with net investment income of $10.0 million ($0.44/share), funded a record $93.9 million across seven portfolio companies (three new), grew the portfolio to $364.0 million, and declared a $0.34 dividend for the seventh consecutive quarter.
Bullish
- + Record net investment income of $10.0 million, or $0.44 per share, up from $8.3 million ($0.36) in Q4 2025 new
- + Record originations of $93.9 million funded across seven portfolio companies including three new borrowers
- + Portfolio grew to a record $364.0 million, up $30.7 million from prior quarter new
- + NAV per share increased to $13.33, up $0.03 from prior quarter new
- + Weighted average yield of 15.8% versus 10.8% for the average public BDC, with 100% of the debt portfolio senior secured new
- + No non-accruals versus industry average of 3.4%, and leverage of 0.18x debt-to-equity well below the 1.3x BDC average
Bearish
- − Net expenses rose to $6.7 million from $5.9 million in Q4 2025, driven by higher interest expense on credit facility utilization new
- − Portfolio has only $50 million of remaining borrowing capacity under a $100 million credit facility (plus $1.5 million cash), constraining growth without further capital raising new
- − Outcomes remain dependent on pending June 29 administrative hearing and potential recreational cannabis rescheduling, expected to conclude by July 15 new
- − Non-cannabis portfolio growth has outpaced cannabis, which may limit direct exposure to the rescheduling tailwind new
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Low
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
+6%
above
RSI (14)
70
neutral
MACD trend
Positive
52-week position
60%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
+3%
trailing
YTD return
0%
this year
Relative strength
−10%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +14 funds added
Insider flow
Accumulating
Net +$1.2M over 90 days · 0% sells
Short interest
Rising
0.47% of float · ▲ +0.9% MoM · 2.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
48 holders — near 3-yr high, broad support
Squeeze score
51
elevated · 0–100
Fundamentals
EPS growth
+57%
Y/Y
Valuation
P/E 7.3
below peers
Buyback
$25.0M
authorized
Quant / Vol
risk profile
Volatility
24%
annualized · 1-yr
Max drawdown
−20%
past year
ATR
2.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
+6%
Bullish
RSI (14)
70
Neutral
MACD trend
Positive
Bullish
52-week position
60%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $10 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +14 funds added
Insider flow
Accumulating
Net +$1.2M over 90 days · 0% sells
Short interest
Rising
0.47% of float · ▲ +0.9% MoM · 2.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
48 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9
Now $10 · 60%
Range high $11
vs 200-day avg +3%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Gross weighted average yield of debt investments | 16% | Q2 2026 | — |
| Internally agented deals (% of portfolio companies) | 81.1% | Q2 2026 | — |
| Investments at fair value | $334.8M | Q2 2026 | — |
| Loans closed across platform since inception | 210 | as of Q2 2026 | — |
| Loans on non-accrual status (% of portfolio at fair value) | 0% | Q2 2026 | — |
| Non-accruals at cost (%) | 0% | Q2 2026 | — |
| Number of portfolio companies | 37 | Q2 2026 | — |
|
|
|||
| Total investment portfolio at fair value | $334.8M | Q2 2026 | — |
| Total portfolio investment fair value | $335M | Q2 2026 | — |
| Weighted average yield on debt investments | 16% | Q2 2026 | — |
| 2nd Lien, Sub & Equity Exposure | 1.3% | as of 3.31.2026 | — |
| Average Portfolio Yield of Public BDCs | 14.6% | as of 3.31.2026 | — |
| Common shares issued and outstanding | 22,820,590 | Q1 2026 | — |
|
|
|||
| Debt portfolio consists of fixed-rate or floating-rate loans at their contractual floors | 94% | Q1 - 2026 | — |
| Fair Market Value of Investment Portfolio | $364M | Q1 - 2026 | — |
| Funded portfolio companies during the quarter (aggregate par value) | $93.9M | Q1 2026 | — |
| GAAP Leverage Ratio | 17.9% | as of 3.31.2026 | — |
| Liquidity | $48.8M | Q1 2026 | — |
|
|
|||
| Total | $363,966,713 | as of March 31, 2026 | — |
| Total investment portfolio | $364M | Q1 2026 | — |
| Available liquidity | $77.9M | Q4 FY2025 | — |
| Average Position Size | 10.4% | FYE 12/31/25 | — |
| Dividend Yield | 13.2% | As of 12/31/25 | — |
| NAV per share | $13.3 | Q4 FY2025 | — |
| Portfolio companies | 39 | Q4 FY2025 | — |
| Portfolio Companies EBITDA (Median) | $10.3M | FYE 12/31/25 | — |
| Portfolio Companies Revenue (Median) | $82.9M | FYE 12/31/25 | — |
| Post-Origination PIK | 0% | FYE 12/31/25 | — |
| Principal amortization and repayments | $11M | Q4 FY2025 | — |
| Total Investments | $333,311,787 | As of 12/31/25 | — |
| Weighted Average Portfolio Yield on Debt Investments | 15.8% | As of 12/31/25 | — |
| Weighted average yield | 15.8% | Q4 FY2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LIEN
this stock
Chicago Atlantic BDC, Inc.
|
$232.77M | +0.1% | — | 7.3 | 0.5% |
|
BLK
BlackRock, Inc.
|
$375.52B | +8.0% | +16.2% | 27.7 | 0.6% |
|
BX
Blackstone Inc.
|
$107.52B | -7.1% | +9.2% | 32.1 | 2.9% |
|
KKR
KKR & Co. Inc.
|
$97.56B | -13.9% | -11.0% | — | 1.4% |
|
BN
BROOKFIELD Corp /ON/
|
$92.02B | -10.2% | — | — | 0.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LIEN | +1.9% | +10.9% | +3.4% | +11.9% | +0.1% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | +1.4% | +9.7% | -9.9% | +9.2% | -12.4% |
Capital returns
Latest dividend
$0.34
/ share · ex Jun 26, 2026
Declared · upcoming
$0.34
/ share · ex Sep 25, 2026
Paid (TTM)
$1.36
/ share · 4 payouts
Dividend yield (TTM, derived)
13.15%
Buyback program
· as of Jun 17, 2026
Authorized
$25.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1843162
CUSIP
828174102
13F (30d)
35 filings
35 filers
Visit website
Investor relations